Research and Markets: Global Melanoma Pipeline Review 2015
November 27 2015 - 10:17AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/hbb5t3/melanoma) has
announced the addition of the "Melanoma - Pipeline Review, 2015"
report to their offering.The report provides comprehensive
information on the pipeline products with comparative analysis of
the products at various stages of development. The report reviews
major players involved in the pipeline product development. It also
provides information about clinical trials in progress, which
includes trial phase, trial status, trial start and end dates, and,
the number of trials for the key Melanoma diagnostic tests pipeline
products.Scope
- Extensive coverage of the Melanoma diagnostic tests under
development
- The report reviews details of major pipeline products which
includes, product description, licensing and collaboration details
and other developmental activities
- The report reviews the major players involved in the
development of Melanoma diagnostic tests and list all their
pipeline projects
- The coverage of pipeline products based on various stages of
development ranging from Early Development to Approved / Issued
stage
- The report provides key clinical trial data of ongoing trials
specific to pipeline products
- Recent developments in the segment / industry
Key Topics Covered:1 Tables & Figures2 Introduction3
Products under Development4 Melanoma - Pipeline Products under
Development by Companies5 Melanoma Companies and Product Overview6
Melanoma- Recent Developments7 AppendixCompanies Mentioned
- Abbott Diagnostics
- Adaptive Biotechnologies Corporation
- Advanced Cell Diagnostics, Inc.
- Agilent Technologies, Inc.
- BioMarker Strategies, LLC
- Biosceptre (Aust) Pty Ltd
- Boston University
- Ceres Nanosciences, Inc.
- Dana-Farber Cancer Institute, Inc.
- Digna Biotech, S.L.
- Exosomics Siena SpA
- Genomic Health, Inc.
- Hospital Universitario Cruces
- HTG Molecular Diagnostics, Inc.
- ImmunID Technologies
- InterGenetics Incorporated
- IV Diagnostics, Inc.
- Louisville Bioscience, Inc.
- MDNA Life Sciences, Inc.
- Melanovus Oncology, Inc.
- MolecularMD, Corp.
- Myriad Genetics, Inc.
- Orion Genomics LLC
- Oryzon Genomics S.A.
- Pacific Edge Limited
- Qiagen N.V.
- Roche Diagnostics International Ltd.
- Rosetta Genomics, Ltd.
- Sividon Diagnostics GmbH
- SomaLogic, Inc.
- The Johns Hopkins University
- Zymera, Inc
For more information visit
http://www.researchandmarkets.com/research/hbb5t3/melanoma
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151127005282/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: In Vitro Diagnostics, Skin Cancer